Sound Bioventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
NephroDInephrodi.comJun 2024
Nephrodi is a biotechnology company developing treatments for kidney conditions, including the rare disease Nephrogenic Diabetes Insipidus (NDI).
BiotechHealthtechMedical DevicesSeattle, US
Jeff M. Sands, M.D.(Executive Officer)Jeff M. Sands(Chief Medical Officer & Founder)Janet D. Klein(Director of Biology & Founder)Rachael Hagan(President & Chief Executive Officer)inFred Callori(Director)Donna See(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.